Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-414-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2017 - October 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study performed according to OECD Guideline 492 without any deviation
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted 28 July 2015
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Resinoid of Ferula galbaniflua (Apiaceae) obtained from the exudate by hydrocarbon ester alcohol extraction.
- EC Number:
- 946-414-3
- Molecular formula:
- Not applicable (UVCB)
- IUPAC Name:
- Resinoid of Ferula galbaniflua (Apiaceae) obtained from the exudate by hydrocarbon ester alcohol extraction.
- Test material form:
- liquid: viscous
- Details on test material:
- Appearance: very viscous liquid, brown to brown red
Substance type: UVCB (Natural Complex Substance)
CAS-No: 9000-24-2
EINECS-No: 232-532-6
Test substance storage: Dry area, unopened containers, optimum temp. 11-25°C
Purpose of testing: REACH
Date of expiration: 18 May 2020
Constituent 1
Test animals / tissue source
- Species:
- other: Reconstructed human Cornea-like Epithelia
- Details on test animals or tissues and environmental conditions:
- - Description of the cell system used: 0.60 cm² Reconstructed human Cornea-like Epithelia [EpiOcular(TM) OCL-212-ver2.0, supplied by MatTek Corporation]
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Concentration: Undiluted - Duration of treatment / exposure:
- 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions)
- Duration of post- treatment incubation (in vitro):
- - Post-exposure immersion period: 12 minutes at room temperature
- Post-exposure incubation period: 2 hours at standard culture conditions - Number of animals or in vitro replicates:
- Test item, negative and positive controls were applied on duplicate tissues.
- Details on study design:
- MAIN TEST
- Pre-incubation of the tissues:
On the day of receipt, the tissues were equilibrated at room temperature for 15 minutes. Then the inserts (filter + epithelium) were gently removed from the agarose while avoiding leaving agarose on the polycarbonate filter. They were placed in 6 wells culture plate which had been previously filled with 1 mL of 37°C pre-warmed assay medium and incubated during 20 hours and 10 minutes for the first run, 20 hours for the second run and 19 hours and 45 minutes for the third run, at standard culture conditions.
After the overnight incubation, the tissues were pre-wetted with 20 μL of Ca2+Mg2+Free-DPBS. The tissues were incubated at standard culture conditions for 30 minutes.
- Treatment and post-treatment incubation of the tissues:
The test item was applied, as supplied, at the dose of 50 μL, to 2 living PBS pre-treated RhCE (EpiOcular™ tissue model) during 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions). In the same experimental conditions, a positive control (Methyl acetate), and a negative control (distilled water) were used. The controls were applied, as supplied, at the dose of 50 µL, to the surface of 2 viable RhCE tissue replicates during 30 minutes at standard culture conditions.
After the treatment, the test item and control substances were carefully washed from the RhCE tissues by extensive rinsing with Ca2+Mg2+Free-DPBS. The rinsed tissues were checked for any colouration and noted for comparable colour with the negative control. This rinsing step was followed by a 12-minute post-exposure immersion period at room temperature in 5 mL of fresh medium to remove any test item absorbed into the tissue. The RhCE constructs were then incubated for about a 2-hour post-exposure incubation (1 hour and 59 minutes for the first run,2 hours for the second and third run) at standard culture conditions in 1 mL of fresh medium at 37°C, 5% CO2.
- MTT viability assay:
Following the exposure to the test item, viability measurements are performed immediately after the post-exposure incubation period of the rinsed tissues in fresh medium. This period allows both for recovery from weak cytotoxic effects and for appearance of clear cytotoxic effects.
The RhCE tissue viability was measured by enzymatic conversion of the vital dye MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Thiazolyl blue tetrazolium bromide; CAS No. 298-93-1] by the viable cells of the tissue into a blue MTT formazan salt that is quantitatively measured by Optical Density (OD) after extraction from tissues. The measured OD was proportional to the number of living cells.
The RhCE constructs were placed in 300 µL of a MTT solution at 1.0 mg/mL for 3 hours at standard culture conditions. The precipitated blue formazan product was then extracted from the tissues by placing each insert in 2 mL of isopropanol during 17 hours and 35 minutes for the first run, during 18 hours and 45 minutes for the second run and during 17 hours and 20 minutes for the third run, at 6±3°C in the dark. The concentration of formazan was measured by determining the OD at 570 nm, just after dilution of the extractions in isopropanol (1:2). The OD measurement of formazan extracts at 570 nm was measured in triplicate samples using the ELx800 absorbance microplate reader (controlled every year and calibrated if necessary) supplied by BioTek and the validated software Gen5 ELISA V1.05.11 supplied by BioTek.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- other: % mean viability of the tissues
- Run / experiment:
- First run mean value
- Value:
- 61.83
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- other: % mean viability of the tissues
- Run / experiment:
- Second run mean value
- Value:
- 55.27
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- other: % mean viability of the tissues
- Run / experiment:
- Third run mean value
- Value:
- 65.97
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- MAIN TEST
MTT assay results:
- The mean percent tissue viability of the RhCE replicates treated with the test item was 61.83% versus 24.44% in the positive control (Methyl acetate).
A second test was run leading to mean percent tissue viability of 55.27% for the test item and 32.69% for the positive control. As no conclusion could be drawn from these 2 tests, a 3rd one was performed. This run led to mean percent tissue viability of 65.97% or the test item and 44.19% for the positive control.
Refer Tables 7.3.2/1 for more details.
Any other information on results incl. tables
Table 7.3.2/1: Main test - Individual and mean corrected OD values and tissue viabilities for the test item, the negative and positive controls
Tissue |
OD |
Mean OD/disc (#) |
Mean OD/product |
Viability % |
Mean viability % |
Difference of viability % |
|
Negative control |
1 |
0.846 |
0.839 |
0.845 |
99.29 |
100.00 |
1.42 |
0.835 |
|||||||
0.836 |
|||||||
2 |
0.845 |
0.851 |
100.71 |
||||
0.855 |
|||||||
0.854 |
|||||||
Positive control |
1 |
0.227 |
0.214 |
0.207 |
25.33 |
24.44 |
1.78 |
0.211 |
|||||||
0.205 |
|||||||
2 |
0.202 |
0.199 |
23.55 |
||||
0.198 |
|||||||
0.198 |
|||||||
Test item |
1 |
0.507 |
0.511 |
0.523 |
60.47 |
61.83 |
2.72 |
0.517 |
|||||||
0.509 |
|||||||
2 |
0.537 |
0.534 |
63.20 |
||||
0.540 |
|||||||
0.526 |
#: mean of 3 values (triplicate of the same extract)
OD: optical density
Second Main test - Individual and mean corrected OD values and tissue viabilities for the test item, the negative and positive controls
Tissue |
OD |
Mean OD/disc (#) |
Mean OD/product |
Viability % |
Mean viability % |
Difference of viability % |
|
Negative control |
1 |
1.036 |
1.023 |
1.034 |
98.94 |
100.00 |
2.13 |
1.012 |
|||||||
1.022 |
|||||||
2 |
1.063 |
1.045 |
101.06 |
||||
1.036 |
|||||||
1.037 |
|||||||
Positive control |
1 |
0.357 |
0.357 |
0.338 |
34.53 |
32.69 |
3.68 |
0.360 |
|||||||
0.353 |
|||||||
2 |
0.394 |
0.319 |
30.85 |
||||
0.352 |
|||||||
0.210 |
|||||||
Test item |
1 |
0.600 |
0.592 |
0.572 |
57.25 |
55.27 |
3.97 |
0.588 |
|||||||
0.589 |
|||||||
2 |
0.557 |
0.551 |
53.29 |
||||
0.544 |
|||||||
0.558 |
Third Main test - Individual and mean corrected OD values and tissue viabilities for the test item, the negative and positive controls
Tissue |
OD |
Mean OD/disc (#) |
Mean OD/product |
Viability % |
Mean viability % |
Difference of viability % |
|
Negative control |
1 |
0.829 |
0.849 |
0.861 |
98.61 |
100.00 |
2.79 |
0.861 |
|||||||
0.857 |
|||||||
2 |
0.889 |
0.873 |
101.39 |
||||
0.909 |
|||||||
0.822 |
|||||||
Positive control |
1 |
0.356 |
0.346 |
0.381 |
40.19 |
44.19 |
8.01 |
0.333 |
|||||||
0.350 |
|||||||
2 |
0.463 |
0.415 |
48.20 |
||||
0.404 |
|||||||
0.380 |
|||||||
Test item |
1 |
0.574 |
0.578 |
0.568 |
67.13 |
65.97 |
2.32 |
0.581 |
|||||||
0.581 |
|||||||
2 |
0.545 |
0.558 |
64.81 |
||||
0.568 |
|||||||
0.562 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Considering the mean viability of 61.02% obtained with the three runs performed, the test item does not require classification for eye irritation or serious eye damage according to Regulation EC No. 1272/2008.
- Executive summary:
The aim of the study was to evaluate the eye hazard potential of the test item GALBANUM RDE SUPER INDE after topical administration on in vitro reconstructed human cornea-like epithelium tissues (EpiOcularTM tissue model).
The test item GALBANUM RDE SUPER INDE was applied, as supplied, at the dose of 50 μL, to 2 living PBS pre-treated RhCE (EpiOcularTM tissue model) during 30 minutes at 37°C, 5% CO2, 95% humidity (standard culture conditions). The exposure period was followed by extensive rinsing with PBS at room temperature, a 12 minutes post-exposure immersion period at room temperature and a 2 hours post-exposure incubation at standard culture conditions. The tissue viability was measured by performing an MTT assay. The experimental protocol was established in accordance with O.E.C.D. Test Guideline No. 492 adopted 28 July 2015.
The mean percent tissue viability of the RhCE replicates treated with the test item GALBANUM RDE SUPER INDE was 61.83 %, versus 24.44% in the positive control (Methyl acetate).
Results were borderline, insofar as mean percent tissue viability equal to 61.83 ± 2.72%, so a second test was performed under the same experimental conditions.
During the 2nd run, the mean corrected percent tissue viability of the RhCE replicates treated with the test item was 55.27%, versus 32.69% in the positive control (Methyl acetate).
As this result is discordant with the result of the first test, a third test was considered.
During the 3rd run, the mean corrected percent tissue viability of the RhCE replicates treated with the test item was 65.97%, versus 44.19% in the positive control (Methyl acetate).
Considering the mean viability of 61.02% obtained with the three runs performed, the test item does not require classification for eye irritation or serious eye damage. It corresponds to the UN GHS No Category.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.